Human Vγ9Vδ2-T cells efficiently kill influenza virus-infected lung alveolar epithelial cells

Cellular and Molecular Immunology

Volumn 10, Issue 2, 2013, Pages 159-164

  Li, Hong ^a,c   Xiang, Zheng ^b   Feng, Ting ^a   Li, Jinrong ^a   Liu, Yinping ^b   Fan, Yingying ^a   Lu, Qiao ^a   Yin, Zhongwei ^a   Yu, Meixing ^a   Shen, Chongyang ^a   Tu, Wenwei ^b  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SICHUAN UNIVERSITY   (China)

Author keywords

A549 cells; influenza A virus; PAM; Vc9Vd2 T cell

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GRANZYME B; PAMIDRONIC ACID; PERFORIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; CELL ACTIVITY; CELL EXPANSION; CELL INTERACTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; GAMMA DELTA T LYMPHOCYTE; GROWTH INHIBITION; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS; LUNG ALVEOLUS EPITHELIUM; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TARGET CELL DESTRUCTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; DIPHOSPHONATES; DOGS; EPITHELIAL CELLS; HUMANS; INFLUENZA A VIRUS; PULMONARY ALVEOLI; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 84874641643     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2012.70     Document Type: Article

References (33)

1. Hu C, Qian L, Miao Y, Huang Q, Miao P, Wang P et al. Antigenpresenting effects of effector memory Vgamma9Vdelta2 T cells in rheumatoid arthritis. Cell Mol Immunol 2012; 9: 245-254.
2. Zhao H, Xi X, Cui L, He W. CDR3delta-grafted gamma9delta2T cells mediate effective antitumor reactivity. Cell Mol Immunol 2012; 9: 147-154.
3. Zheng J, Liu Y, Lau YL, Tu W. Gammadelta-T cells: an unpolished sword in human anti-infection immunity. Cell Mol Immunol 2012; in press.
4. Zhou J, Kang N, Cui L, Ba D, He W. Anti-gammadelta TCR antibodyexpanded gammadelta T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies. Cell Mol Immunol 2012; 9: 34-44.
5. Born WK, Reardon CL, O'Brien RL. The function of gammadelta T cells in innate immunity. Curr Opin Immunol 2006; 18: 31-38.
6. Carding SR, Egan PJ. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002; 2: 336-345.
7. Beetz S, Wesch D, Marischen L, Welte S, Oberg HH, Kabelitz D. Innate immune functions of human gammadelta T cells. Immunobiology 2008; 213: 173-182.
8. Qin G, Mao H, Zheng J, Sia SF, Liu Y, Chan PL et al. Phosphoantigenexpanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J Infect Dis 2009; 200: 858-865.
9. Puan KJ, Jin C, Wang H, Sarikonda G, Raker AM, Lee HK et al. Preferential recognition of a microbial metabolite by human Vgamma2Vdelta2 T cells. Int Immunol 2007; 19: 657-673.
10. Traggiai E, Volpi S, Schena F, Gattorno M, Ferlito F, Moretta L et al. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 2008; 26: 562-569.
11. Tu W, Zheng J, Liu Y, Sia SF, Liu M, Qin G et al. The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice. J Exp Med 2011; 208: 1511-1522.
12. Bukowski JF, Morita CT, Brenner MB. Recognition and destruction of virus-infected cells by human gamma delta CTL. J Immunol 1994; 153: 5133-5140.
13. Halary F, Pitard V, Dlubek D, Krzysiek R, de la Salle H, Merville P et al. Shared reactivity of Vd2negcd T cells against cytomegalovirusinfected cells and tumor intestinal epithelial cells. J Exp Med 2005; 201: 1567-1578.
14. Poccia F, Agrati C, Castilletti C, Bordi L, Gioia C, Horejsh D et al. Antisevere acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells. J Infect Dis 2006; 193: 1244-1249.
15. Poccia F, Agrati C, Martini F, Capobianchi MR, Wallace M, Malkovsky M. Antiviral reactivities of gammadelta T cells. Microbes Infect 2005; 7: 518-528.
16. Poccia F, Agrati C, Martini F, Mejia G, Wallace M, Malkovsky M. Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy. Immunol Lett 2005; 100: 14-20.
17. Poccia F, Cipriani B, Vendetti S, Colizzi V, Poquet Y, Battistini L et al. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes. J Immunol 1997; 159: 6009-6017.
18. Sciammas R, Bluestone JA. TCRgammadelta cells and viruses. Microbes Infect 1999; 1: 203-212.
19. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360: 1831-1837.
20. Qin G, Liu Y, Zheng J, Ng IH, Xiang Z, LamKT et al. Type 1 responses of human Vgamma9Vdelta2 T cells to influenza A viruses. J Virol 2011; 85: 10109-10116.
21. Qin G, Liu Y, Zheng J, Xiang Z, Ng IH, Malik Peiris JS et al. Phenotypic and functional characterization of human gammadelta T-cell subsets in response to influenza A viruses. J Infect Dis 2012; 205: 1646-1653.
22. Boullier S, Poquet Y, Halary F, Bonneville M, Fournie JJ, Gougeon ML. Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD942 peripheral Vgamma9 Vdelta2 T cells but not on CD942 thymic or mature gammadelta T cell clones. Eur J Immunol 1998; 28: 3399-3410.
23. Tu W, Mao H, Zheng J, Liu Y, Chiu SS, Qin G et al. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 2010; 84: 6527-6535.
24. Zeine R, Pon R, Ladiwala U, Antel JP, Filion LG, Freedman MS.Mechanism of gammadelta T cell-induced human oligodendrocyte cytotoxicity: relevance to multiple sclerosis. J Neuroimmunol 1998; 87: 49-61.
25. Agrati C, Alonzi T, de Santis R, Castilletti C, Abbate I, CapobianchiMR et al. Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication. Int Immunol 2006; 18: 11-18.
26. Alexander AA, Maniar A, Cummings JS, Hebbeler AM, Schulze DH, Gastman BR et al. Isopentenyl pyrophosphate-activated CD561 cd T lymphocytes display potent antitumor activity toward human squamous cell carcinoma. Clin Cancer Res 2008; 14: 4232-4240.
27. Gonzalez S, Lopez-Soto A, Suarez-Alvarez B, Lopez-Vazquez A, Lopez-Larrea C. NKG2D ligands: key targets of the immune response. Trends Immunol 2008; 29: 397-403.
28. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997; 7: 831-836.
29. Fujishima N, Hirokawa M, Fujishima M, Yamashita J, Saitoh H, Ichikawa Y et al. Skewed T cell receptor repertoire of Vdelta11 gammadelta T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction. Clin Exp Immunol 2007; 149: 70-79.
30. Voss D, Pfefferle S, Drosten C, Stevermann L, Traggiai E, Lanzavecchia A et al. Studies on membrane topology, Nglycosylation and functionality of SARS-CoV membrane protein. Virol J 2009; 6: 79.
31. Das H, Groh V, Kuijl C, Sugita M, Morita CT, Spies T et al. MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 2001; 15: 83-93.
32. Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T. Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol 2005; 175: 2144-2151.
33. Dalton JE, Howell G, Pearson J, Scott P, Carding SR. Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells. J Immunol 2004; 173: 3660-3667.